Queen's Medical Centre
Queen's Medical Centre
Nottingham, United Kingdom5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06632444 | |
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Recruiting | Phase 3 | 2026-05-13 | NCT05677971 | |
| Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Phase 3 | 2026-05-04 | NCT03301506 | |
| A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis | Brain Diseases, Metabolic, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, brain disorder, central nervous system disorder, cirrhosis of liver, fatty liver disease, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nervous system disorder, substance-related disorder | Recruiting | Phase 3 | 2026-02-24 | NCT06461208 | |
| GEKO Venous Thromboembolism Prevention Study | Deep Vein Thrombosis, Embolism, Embolism and Thrombosis, Stroke, Acute, Thromboembolism, Venous Thrombosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, lung disorder, nervous system disorder, pulmonary embolism, respiratory system disorder, stroke disorder, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Not applicable | 2025-03-04 | NCT05476913 |